| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/17/2013 | US20130274129 Tal-effector assembly platform, customized services, kits and assays |
| 10/17/2013 | US20130273668 Peptide capable for binding to iridium |
| 10/17/2013 | US20130273653 Diagnostic marker for melanoma, pharmaceutical composition comprising inhibitor of the function of the histatin-1 protein and immunosuppressor |
| 10/17/2013 | US20130273647 Antigen-Specific T Cell Receptors and T Cell Epitopes |
| 10/17/2013 | US20130273603 Non-Natural Gelatin-Like Proteins with Enhanced Functionality |
| 10/17/2013 | US20130273542 Detection of gleevec resistance |
| 10/17/2013 | US20130273170 Puumala virus full-length m segment-based dna vaccines |
| 10/17/2013 | US20130273150 Dendritic Cell Marker and Uses Thereof |
| 10/17/2013 | US20130273103 Polyvalent immunogen |
| 10/17/2013 | US20130273095 Vaccine composition for controlling ectoparasite infestations |
| 10/17/2013 | US20130273088 Epitopes of herpes simplex virus |
| 10/17/2013 | US20130273087 Recombinant t-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction |
| 10/17/2013 | US20130273085 Novel P2X7 Epitopes |
| 10/17/2013 | US20130273083 System for Immunotherapy Targeting Tumor Propagation and Progression |
| 10/17/2013 | US20130273044 Compositions and Methods for Diagnosing and Treating Cancer |
| 10/17/2013 | US20130273038 Human cdr-grafted antibody and antibody fragment thereof |
| 10/17/2013 | US20130273000 Methods for treating viral infection using il-28 and il-29 |
| 10/17/2013 | US20130272964 Molecules with extended half-lives, compositions and uses thereof |
| 10/17/2013 | CA2862290A1 Il-12 for radiation protection and radiation-induced toxicity mitigation |
| 10/16/2013 | EP2650683A1 Methods and marker combinations for screening for predisposition to lung cancer |
| 10/16/2013 | EP2650371A2 Method for the microbial production of organic acids, other molecules and bioactive substances from bioplastic materials |
| 10/16/2013 | EP2650305A1 PC5 as a factor IX propeptide processing enzyme |
| 10/16/2013 | EP2650304A1 Antimicrobial peptide multiblock copolymer to be expressed on surface of cells |
| 10/16/2013 | EP2650303A1 Methods and compositions for the treatment of heart failure and other disorders |
| 10/16/2013 | EP2650302A1 Method for removing endotoxin from proteins |
| 10/16/2013 | EP2650020A1 Trimeric OX40-immunoglobulin fusion protein and methods of use |
| 10/16/2013 | EP2650015A2 Compositions and methods of use of ORF 554 from beta hemolytic Streptococcal strains |
| 10/16/2013 | EP2650014A2 Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains |
| 10/16/2013 | EP2650006A1 Analogues of exendin-4 and exendin-3 |
| 10/16/2013 | EP2650003A1 Degradable clostridial toxins |
| 10/16/2013 | EP2649096A2 Hemoglobin compositions and methods of use |
| 10/16/2013 | EP2649095A2 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases |
| 10/16/2013 | EP2649094A1 Methods and compositions comprising il-7 receptor ligands |
| 10/16/2013 | EP2649093A1 Biomarkers for the diagnosis of multiple sclerosis |
| 10/16/2013 | EP2649092A1 Modified protein body tags and production methods thereof |
| 10/16/2013 | EP2649091A1 Immune restricted peptides with increased efficacy |
| 10/16/2013 | EP2649090A2 PEPTIDES THAT MODULATE COMPLEX SASPase-FLG2 |
| 10/16/2013 | EP2648746A1 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof |
| 10/16/2013 | EP2648744A2 Malaria vaccines based on pre-erythrocytic antigens from p. falciparum |
| 10/16/2013 | EP2648743A2 Agents for increased resistance against oxidative stress conditions |
| 10/16/2013 | EP2648735A2 Granzyme b inhibitor compositions, methods and uses for promoting wound healing |
| 10/16/2013 | CN103354748A Modified hepatitis c virus proteins |
| 10/16/2013 | CN103354715A Citrus trees with resistance to citrus canker |
| 10/16/2013 | CN103352063A Method for extracting and concentrating type II collagen |
| 10/16/2013 | CN103352041A Fungal cellulase system constitution/characteristic regulatory gene and application thereof |
| 10/16/2013 | CN103352040A Soybean glucose phosphate transporter gene and protein encoded by the same |
| 10/16/2013 | CN103352039A Corn disease-resistance related gene MR6, and application of the same in corn disease-resistance improvement |
| 10/16/2013 | CN103352038A Corn disease-resistance related gene MR4, and application of the same in corn disease-resistance improvement |
| 10/16/2013 | CN103351433A Benzoic acid artificial antigen and antibody, and preparation methods and applications thereof |
| 10/16/2013 | CN103351432A Technology for extracting human blood coagulation factor VIII and human fibrinogen from plasma constituent precipitation |
| 10/16/2013 | CN103351431A Coagulation factor 8 and its mutant purifying method |
| 10/16/2013 | CN103351430A Fish nuclear factor 45 and application thereof |
| 10/16/2013 | CN103351429A Transcription factor for regulating plant oils and fatty acids, coding gene and application thereof |
| 10/16/2013 | CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 10/16/2013 | CN102875660B Virus induced protein Mig1 and application thereof |
| 10/16/2013 | CN102702346B Method for extracting acid-soluble collagen from fish skin and extracted product |
| 10/16/2013 | CN102690335B Polypeptide for effectively inhibiting activity of influenza virus polymerase |
| 10/16/2013 | CN102676542B Gene sequence of Chinese cabbage dehydration transcription factor BpDREB1 and application thereof |
| 10/16/2013 | CN102676425B Bacillus amyloliquefaciens 906 and bacteriocin produced by bacillus amyloliquefaciens 906 and applications |
| 10/16/2013 | CN102617722B Ancylostoma caninum anticoagulant peptide, preparation and application thereof |
| 10/16/2013 | CN102584971B Plant growth and development related protein ABP7 and coding gene and application thereof |
| 10/16/2013 | CN102559689B Prawn complement 1q binding protein and application thereof |
| 10/16/2013 | CN102558327B Process for extracting sweet potato protein by thermal deposition method |
| 10/16/2013 | CN102533788B EADT1 gene capable of improving drought resistance of rice in growth period, coding sequence and application |
| 10/16/2013 | CN102516379B Separating from Stomolophus meleagris L. Agassiz nematocyst venom of protein having superoxide anion-clearing activity |
| 10/16/2013 | CN102477088B Protein related to plant salt resistance, coding gene thereof, and application thereof |
| 10/16/2013 | CN102432678B Drought stress response protein of rice in flowering phase, coding gene and application thereof |
| 10/16/2013 | CN102250923B cryIAc gene having high lepidopteran pest resistance and application thereof in sugarcane |
| 10/16/2013 | CN102070714B Method for separating and purifying recombined proserum |
| 10/16/2013 | CN101960014B Cell lines and methods for making and using them |
| 10/16/2013 | CN101935342B Moth orchid development B gene-PhAP3 coded sequence and application thereof |
| 10/16/2013 | CN101602796B Selenium-containing active polypeptide, preparing method and application thereof |
| 10/16/2013 | CN101595222B Plants having enhanced seed yield-related traits and a method for making the same |
| 10/16/2013 | CN101553499B Process for generation of protein and uses thereof |
| 10/16/2013 | CN101517096B Use of DKK-1 protein in cancer diagnosis |
| 10/16/2013 | CN101245101B Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146 |
| 10/15/2013 | US8558092 Inbred corn line ML8 |
| 10/15/2013 | US8558091 Plants and seeds of corn variety CV047114 |
| 10/15/2013 | US8558083 Maize variety inbred PH1CJB |
| 10/15/2013 | US8558076 Soybean cultivar 8595250112 |
| 10/15/2013 | US8558059 Genes for conferring to plants increased tolerance to environmental stresses |
| 10/15/2013 | US8558048 Stabilized protein crystals, formulations comprising them and methods of making them |
| 10/15/2013 | US8557989 Electrochemical affinity biosensor system and methods |
| 10/15/2013 | US8557965 Single variable domains against notch pathway members |
| 10/15/2013 | US8557961 Alpha 1-antitrypsin compositions and methods of making and using same |
| 10/15/2013 | US8557956 Aligned polymers including bonded substrates |
| 10/15/2013 | US8557777 Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides |
| 10/15/2013 | US8557773 Treatment of bleeding with low half-life fibrinogen |
| 10/15/2013 | US8557772 Compositions having antiangiogenic activity and uses thereof |
| 10/15/2013 | US8557771 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
| 10/15/2013 | US8557768 Human nerve growth factor by recombinant technology |
| 10/15/2013 | US8557762 Snake factor V and methods of use thereof as a procoagulant |
| 10/15/2013 | US8557603 Synthetic peptides, methods and kits for diagnosing autoimmune diseases |
| 10/15/2013 | US8557573 Vector particles for targeting CD34+ cells |
| 10/15/2013 | US8557546 Recombinant human G-CSF dimer and use thereof for the treatment of neurological diseases |
| 10/15/2013 | US8557543 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor |
| 10/15/2013 | US8557535 Methods for preparation of platelet rich plasma |
| 10/15/2013 | US8557530 Use of a TAS2R7 nucleic acid sequence to identify modulators |
| 10/15/2013 | US8557519 Proteins for use in human and animal Staphyococcus infections |
| 10/15/2013 | US8557512 Method of screening activators and/or inhibitors of insulin receptor substrate 2 |